Advances and opportunities in nanoimaging agents for the diagnosis of inflammatory lung diseases

Hema Brindha Masanam; Govindaraj Perumal; Saravanan Krishnan; Sachin Kumar Singh; Niraj Kumar Jha; Dinesh Kumar Chellappan; Kamal Dua; Piyush Kumar Gupta; Ashwin Kumar Narasimhan

doi:10.2217/nnm-2021-0427

Advances and opportunities in nanoimaging agents for the diagnosis of inflammatory lung diseases

Hema Brindha Masanam
, Govindaraj Perumal
, Saravanan Krishnan
, Sachin Kumar Singh
, Niraj Kumar Jha
, Dinesh Kumar Chellappan
, Kamal Dua
, Piyush Kumar Gupta
, Ashwin Kumar Narasimhan

SRM Institute of Science and Technology
Saveetha Institute of Medical and Technical Sciences (Deemed to be University)
Anna University
Creative Carbon Labs Pvt Ltd
Lovely Professional University
Sharda University
International Medical University
University of Technology Sydney
Graphic Era
INTI International University

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

The development of rapid, noninvasive diagnostics to detect lung diseases is a great need after the COVID-2019 outbreak. The nanotechnology-based approach has improved imaging and facilitates the early diagnosis of inflammatory lung diseases. The multifunctional properties of nanoprobes enable better spatial-temporal resolution and a high signal-to-noise ratio in imaging. Targeted nanoimaging agents have been used to bind specific tissues in inflammatory lungs for early-stage diagnosis. However, nanobased imaging approaches for inflammatory lung diseases are still in their infancy. This review provides a solution-focused approach to exploring medical imaging technologies and nanoprobes for the detection of inflammatory lung diseases. Prospects for the development of contrast agents for lung disease detection are also discussed.

Original language	English
Pages (from-to)	1981-2005
Number of pages	25
Journal	Nanomedicine
Volume	17
Issue number	25
DOIs	https://doi.org/10.2217/nnm-2021-0427
State	Published - 1 Oct 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

contrast agents
imaging nanoparticles
inflammatory lungs diseases
medical imaging
respiratory diseases

Access to Document

10.2217/nnm-2021-0427

Cite this

@article{7467c001002d47c1a77dd5b6b8a0a761,

title = "Advances and opportunities in nanoimaging agents for the diagnosis of inflammatory lung diseases",

abstract = "The development of rapid, noninvasive diagnostics to detect lung diseases is a great need after the COVID-2019 outbreak. The nanotechnology-based approach has improved imaging and facilitates the early diagnosis of inflammatory lung diseases. The multifunctional properties of nanoprobes enable better spatial-temporal resolution and a high signal-to-noise ratio in imaging. Targeted nanoimaging agents have been used to bind specific tissues in inflammatory lungs for early-stage diagnosis. However, nanobased imaging approaches for inflammatory lung diseases are still in their infancy. This review provides a solution-focused approach to exploring medical imaging technologies and nanoprobes for the detection of inflammatory lung diseases. Prospects for the development of contrast agents for lung disease detection are also discussed.",

keywords = "contrast agents, imaging nanoparticles, inflammatory lungs diseases, medical imaging, respiratory diseases",

author = "Masanam, \{Hema Brindha\} and Govindaraj Perumal and Saravanan Krishnan and Singh, \{Sachin Kumar\} and Jha, \{Niraj Kumar\} and Chellappan, \{Dinesh Kumar\} and Kamal Dua and Gupta, \{Piyush Kumar\} and Narasimhan, \{Ashwin Kumar\}",

note = "Publisher Copyright: {\textcopyright} 2023 Future Medicine Ltd.",

year = "2022",

month = oct,

day = "1",

doi = "10.2217/nnm-2021-0427",

language = "English",

volume = "17",

pages = "1981--2005",

journal = "Nanomedicine",

issn = "1743-5889",

publisher = "Taylor and Francis Ltd.",

number = "25",

}

TY - JOUR

T1 - Advances and opportunities in nanoimaging agents for the diagnosis of inflammatory lung diseases

AU - Masanam, Hema Brindha

AU - Perumal, Govindaraj

AU - Krishnan, Saravanan

AU - Singh, Sachin Kumar

AU - Jha, Niraj Kumar

AU - Chellappan, Dinesh Kumar

AU - Dua, Kamal

AU - Gupta, Piyush Kumar

AU - Narasimhan, Ashwin Kumar

PY - 2022/10/1

Y1 - 2022/10/1

N2 - The development of rapid, noninvasive diagnostics to detect lung diseases is a great need after the COVID-2019 outbreak. The nanotechnology-based approach has improved imaging and facilitates the early diagnosis of inflammatory lung diseases. The multifunctional properties of nanoprobes enable better spatial-temporal resolution and a high signal-to-noise ratio in imaging. Targeted nanoimaging agents have been used to bind specific tissues in inflammatory lungs for early-stage diagnosis. However, nanobased imaging approaches for inflammatory lung diseases are still in their infancy. This review provides a solution-focused approach to exploring medical imaging technologies and nanoprobes for the detection of inflammatory lung diseases. Prospects for the development of contrast agents for lung disease detection are also discussed.

AB - The development of rapid, noninvasive diagnostics to detect lung diseases is a great need after the COVID-2019 outbreak. The nanotechnology-based approach has improved imaging and facilitates the early diagnosis of inflammatory lung diseases. The multifunctional properties of nanoprobes enable better spatial-temporal resolution and a high signal-to-noise ratio in imaging. Targeted nanoimaging agents have been used to bind specific tissues in inflammatory lungs for early-stage diagnosis. However, nanobased imaging approaches for inflammatory lung diseases are still in their infancy. This review provides a solution-focused approach to exploring medical imaging technologies and nanoprobes for the detection of inflammatory lung diseases. Prospects for the development of contrast agents for lung disease detection are also discussed.

KW - contrast agents

KW - imaging nanoparticles

KW - inflammatory lungs diseases

KW - medical imaging

KW - respiratory diseases

UR - https://www.scopus.com/pages/publications/85148307198

U2 - 10.2217/nnm-2021-0427

DO - 10.2217/nnm-2021-0427

M3 - Review article

C2 - 36695290

AN - SCOPUS:85148307198

SN - 1743-5889

VL - 17

SP - 1981

EP - 2005

JO - Nanomedicine

JF - Nanomedicine

IS - 25

ER -

Advances and opportunities in nanoimaging agents for the diagnosis of inflammatory lung diseases

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this